Researcher.Life Logo

Critical Reviews in Oncology/Hematology : Impact Factor & More

eISSN: 1879-0461pISSN: 1040-8428

Key Metrics

CiteScore
9.7
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Critical Reviews in Oncology/Hematology

Critical Reviews in Oncology/Hematology Journal Specifications

Overview
Publisher ELSEVIER SCIENCE INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1989
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Critical Reviews in Oncology/Hematology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Critical Reviews in Oncology/Hematology

Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): 'Where the streets have no name'.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Pulmonary microbiota is a hidden link between lung cancer Development and microenvironment: Potential for future immune therapeutic strategies.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Recent advancements of neoadjuvant strategies in locally advanced rectal cancer.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Evaluating quality of life in thoracic malignancy trials: A scoping review on ESMO-MCBS quality of life checklist adherence and concordance with progression-free and overall survival.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Salivary phosphate: A promising non-invasive biomarker for oral and systemic disease screening.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): 'Where the streets have no name'.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Pulmonary microbiota is a hidden link between lung cancer Development and microenvironment: Potential for future immune therapeutic strategies.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Recent advancements of neoadjuvant strategies in locally advanced rectal cancer.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Evaluating quality of life in thoracic malignancy trials: A scoping review on ESMO-MCBS quality of life checklist adherence and concordance with progression-free and overall survival.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology
Salivary phosphate: A promising non-invasive biomarker for oral and systemic disease screening.
  • 1 Jul 2026
  • Critical reviews in oncology/hematology

FAQs on Critical Reviews in Oncology/Hematology